CA-INSEEGO-CORP
26.7.2022 13:03:16 CEST | Business Wire | Press release
Inseego Corp. (Nasdaq: INSG) announced today that the Inseego Wavemaker™ FX2000 5G indoor router is now being sold to customers on the Three Sweden network. Three Sweden is part of Three Group Europe, which includes networks in Austria, Denmark, Italy, Ireland, Sweden and the United Kingdom.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220726005524/en/
The award-winning FX2000 fixed wireless access (FWA) router can deliver gigabit speeds for fast and reliable internet access, along with Wi-Fi 6 for up to 30 devices, making it ideal for remote work, streaming and gaming. With its small, elegant design and simple setup, it fits into any environment, from home offices to summer cottages.
“We’re proud to provide this fixed wireless access solution to Three Sweden and their customers,” said Simon Rayne, senior vice president and managing director, UK, EMEA, and Asia-Pacific for Inseego. “This is the first commercial launch of our FX2000 with a European carrier, and we look forward to many more. Our 5G solutions are changing the way millions of people stay connected at home, in the office, and on the move.”
“This router is an excellent choice for our customers who want the speed and simplicity of 5G home internet,” said Rune Pedersen, CCO Consumer Market at Three Sweden. “Combined with our unlimited 3Bredband Max, it’s an easy, affordable way to plug into the power of new 5G experiences.”
Speed, simplicity and flexibility: With its small footprint and low profile, the FX2000 fits into any setting. It can be placed on a tabletop or desktop and moved easily when relocating to a new home or office.
Easy setup and management: The FX2000 can be set up by anyone (no service technician needed) in just a few minutes. The Inseego Mobile smartphone app makes it easy to choose the best placement and manage the FX2000 with user-friendly control settings.
Best-in-class performance: With Inseego’s industry-leading antenna and RF technology, the FX2000 can deliver peak 5G speeds over 1 Gbps (depending on network coverage), along with fallback to Cat 22 LTE. Sustained high throughput and low latency 5G connections are ideal for applications such as video conferencing, streaming media, AR/VR and cloud computing. The FX2000 supports dual-band Wi-Fi 6 for up to 30 connected devices, as well as an ethernet LAN port and USB port, to connect up to 32 devices simultaneously. The ethernet LAN port can also be connected to other routing devices.
Enterprise-grade security: Designed and developed in the U.S. with multiple layers of advanced security, the FX2000 safeguards data with advanced encryption, hacker prevention, password protection, OpenVPN, guest Wi-Fi network and more. Robust authentication protects against cyber threats and allows customers to connect with confidence.
To learn more about Inseego 5G products and solutions, please go to inseego.com .
About Inseego Corp.
Inseego Corp. (Nasdaq: INSG) is an industry leader in smart device-to-cloud solutions that extend the 5G network edge, enabling broader 5G coverage, multi-gigabit data speeds, low latency and strong security to deliver highly reliable internet access. Inseego’s mobile broadband, fixed wireless access (FWA) solutions and software platform incorporate the most advanced technologies (including 5G, 4G LTE, Wi-Fi 6 and others) into a wide range of innovative products that provide robust connectivity indoors, outdoors and in the harshest industrial environments. Designed and developed in the USA, Inseego products and SaaS solutions build on the company’s patented technologies to provide the highest quality wireless connectivity for service provider, enterprise, and government entities worldwide. www.inseego.com #Putting5GtoWork
Inseego 5G FX2000 chipset: Qualcomm® Snapdragon® X55 5G Modem-RF System.
©2022. Inseego Corp. All rights reserved. The Inseego name and logo name and logo are registered trademarks and Wavemaker is a trademark of Inseego Corp. Other Company, product or service names mentioned herein are the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220726005524/en/
Link:
Social Media:
https://www.facebook.com/Inseego/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom